The cycle will commence with the donor being contacted by the clinic for an initial appointment. She will be asked to come into the clinic for a lengthy visit. At this appointment the donor will meet with the reproductive endocrinologist who will run the cycle, the nursing team in the egg donor program, other egg donor team members, possibly the clinic's social worker and/or psychologist and she will be given a medical exam. Often, as a part of this initial appointment, the donor will participate in a cycle teaching session where she will be introduced and become familiar with the medications, the management of self-injecting the meds and she will be informed of all of the requirements of the cycle. This teaching session is required of all donors, even those experienced with the process.
Usually, at the conclusion of the initial appointment, the donor will be asked to sign clinic consent forms, confirming her understanding of the complexities as well as risks of the cycle and by signing the clinic consent forms she will have expressed her assumption of risks related to the cycle. Some attorneys choose to attach to the Egg Donor Agreement these consent forms to further represent that the donor is of informed status about all matters related to the cycle, Prospective Families endorsed this practice.
If, after this initial appointment, both the clinic and the donor are prepared to begin the cycle, the donor will be asked to sign the Egg Donor Agreement. Once the contract is signed, both the donor and the recipient become obligated and legally liable for all terms of the agreement.
The clinic will notify the agency of when the donor will have a base-line Day 3 blood-draw done. This is a standard blood draw that allows the clinic to assess the donor's readiness for infertility medication by marking the donor's hormonal levels. At this time and possibly along with donor's sexual partner, she may be asked to complete the FDA mandated infectious disease blood-tests, when doing her Day 3 bloods. All clinics vary as to when the donor will do the FDA blood-tests but donor should expect that she will be doing these tests, twice and her partner, if any, may be asked to have the tests, once.
The FDA blood-tests will be done again, later in the cycle and prior to retrieval in an effort to confirm that while donor may have tested negative at the time of the initial screening that she has not contracted an infectious disease since commencing the cycle.
Following the blood draw, the donor and the agency is given a cycle schedule. The agency will stay in regular contact with the clinic and the donor to be sure that all is proceeding with the cycle and that donor is clear on and committed to the cycle schedule.
We are pleased to introduce our new Prospective Families Proprietary Donor Database. Browse our entire list of donors. View photos and other profile information. Search for donors who match your specific criteria. Even save your own secure private list of donors.
The database requires registration. Click here to get started (opens in a new window).
